Impact of cellular senescence signature on ageing research

Ageing Research Reviews

Volumn 10, Issue 1, 2011, Pages 146-152

  Sikora, Ewa ^a   Arendt, Thomas ^b   Bennett, Martin ^c   Narita, Masashi ^d  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Age related disease; Biomarkers; DNA damage; Low grade inflammation; PML; SAHFs; Secretory phenotype; Senescence; Telomeres

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN;

AGING; CELL AGING; CELL PROLIFERATION; DNA DAMAGE; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMAN; NONHUMAN; PHENOTYPE; REVIEW; SENESCENCE; TELOMERE;

AGING; BIOLOGICAL MARKERS; CELL AGING; DNA DAMAGE; GENOMIC INSTABILITY; HUMANS; PHENOTYPE; RESEARCH; TELOMERE;

EID: 78650243948     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2010.10.002     Document Type: Review

References (99)

1. Arendt T., Mosch B., Morawski M. Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons. Int. J. Mol. Sci. 2009, 10:1609-1627.
2. Armanios M., Alder J.K., Parry E.M., Karim B., Strong M.A., Greider C.W. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 2009, 85:823-832.
3. Bandyopadhyay D., Timchenko N., Suwa T., Hornsby P.J., Campisi J., Medrano E.E. The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells. Exp. Gerontol. 2001, 36:1265-1275.
4. Bartkova J., Bakkenist C.J., Rajpert-De Meyts E., Skakkebaek N.E., Sehested M., Lukas J., Kastan M.B., Bartek J. ATM activation in normal human tissues and testicular cancer. Cell Cycle 2005, 4:838-845.
5. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., Orntoft T., Lukas J., Bartek J. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
6. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., Takaoka M., Nakagawa H., Tort F., Fugger K., Johansson F., Sehested M., Andersen C.L., Dyrskjot L., Orntoft T., Lukas J., Kittas C., Helleday T., Halazonetis T.D., Bartek J., Gorgoulis V.G. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
7. Barzilai A., Biton S., Shiloh Y. The role of the DNA damage response in neuronal development, organization and maintenance. DNA Repair (Amst.) 2008, 7:1010-1027.
8. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
9. Blazkova H., Krejcikova K., Moudry P., Frisan T., Hodny Z., Bartek J. Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling. J. Cell. Mol. Med. 2010, 14:357-367.
10. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 1998, 279:349-352.
11. Bourdeau V., Baudry D., Ferbeyre G. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence. Front. Biosci. 2009, 14:475-485.
12. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005, 436:660-665.
13. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: what is the connection?. Nat. Rev. Mol. Cell. Biol. 2010, 11:567-578.
14. Butler R.N., Miller R.A., Perry D., Carnes B.A., Williams T.F., Cassel C., Brody J., Bernard M.A., Partridge L., Kirkwood T., Martin G.M., Olshansky S.J. New model of health promotion and disease prevention for the 21st century. BMJ 2008, 337:a399.
15. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11:S27-31.
16. Campisi J., d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 2007, 8:729-740.
17. Chan H.M., Narita M., Lowe S.W., Livingston D.M. The p400 E1A-associated protein is a novel component of the p53→p21 senescence pathway. Genes Dev. 2005, 19:196-201.
18. Chatoo W., Abdouh M., Bernier G. P53 pro-oxidant activity in the central nervous system: implication in aging and neurodegenerative diseases. Antioxid. Redox. Signal 2010.
19. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., Cordon-Cardo C., Pandolfi P.P. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
20. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., Carter C., Yu B.P., Leeuwenburgh C. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 2009, 8:18-30.
21. Cichowski K., Hahn W.C. Unexpected pieces to the senescence puzzle. Cell 2008, 133:958-961.
22. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., Beach D., Serrano M. Tumour biology: senescence in premalignant tumours. Nature 2005, 436:642.
23. Coppe J.P., Desprez P.Y., Krtolica A., Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 2010, 5:99-118.
24. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat. Rev. Cancer 2008, 8:512-522.
25. Davalos A.R., Coppe J.P., Campisi J., Desprez P.Y. Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 2010, 29:273-283.
26. Davoli T., Denchi E.L., de Lange T. Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 2010, 141:81-93.
27. Di Micco R., Cicalese A., Fumagalli M., Dobreva M., Verrecchia A., Pelicci P.G., di Fagagna F. DNA damage response activation in mouse embryonic fibroblasts undergoing replicative senescence and following spontaneous immortalization. Cell Cycle 2008, 7:3601-3606.
28. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9363-9367.
29. Effros R.B., Dagarag M., Valenzuela H.F. In vitro senescence of immune cells. Exp. Gerontol. 2003, 38:1243-1249.
30. Erusalimsky J.D. Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 2009, 106:326-332.
31. Finch C.E., Morgan T.E. Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper. Curr. Alzheimer Res. 2007, 4:185-189.
32. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
33. Funayama R., Ishikawa F. Cellular senescence and chromatin structure. Chromosoma 2007, 116:431-440.
34. Gamerdinger M., Hajieva P., Kaya A.M., Wolfrum U., Hartl F.U., Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 2009, 28:889-901.
35. Geng Y.Q., Guan J.T., Xu X.H., Fu Y.C. Senescence-associated beta-galactosidase activity expression in aging hippocampal neurons. Biochem. Biophys. Res. Commun. 2010, 396:866-869.
36. Gorenne I., Kavurma M., Scott S., Bennett M. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc. Res. 2006, 72:9-17.
37. Gupta A., Pansari K. Inflammation and Alzheimer's disease. Int. J. Clin. Pract. 2003, 57(1):36-39.
38. Gupta S. Hepatic polyploidy and liver growth control. Semin. Cancer Biol. 2000, 10:161-171.
39. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
40. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
41. Hayflick L. Mortality and immortality at the cellular level-a review. Biochemistry (Mosc.) 1997, 62:1180-1190.
42. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell. Res. 1961, 25:585-621.
43. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
44. Herrup K., Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?. Nat. Rev. Neurosci. 2007, 8:368-378.
45. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
46. Hubackova S., Novakova Z., Krejcikova K., Kosar M., Dobrovolna J., Duskova P., Hanzlikova H., Vancurova M., Barath P., Bartek J., Hodny Z. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling. Cell Cycle 2010, 9:3085-3099.
47. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
48. Jeyapalan J.C., Ferreira M., Sedivy J.M., Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 2007, 128:36-44.
49. Jeyapalan J.C., Sedivy J.M. Cellular senescence and organismal aging. Mech. Ageing Dev. 2008, 129:467-474.
50. Kaji K., Matsuo M. Aging of chick embryo fibroblasts in vitro V. Time course studies on polyploid nucleus accumulation. Exp. Cell Res. 1981, 131:410-412.
51. Kuilman T., Peeper D.S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 2009, 9:81-94.
52. Mahmoudi M., Gorenne I., Mercer J., Figg N., Littlewood T., Bennett M. Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells. Circ. Res. 2008, 103:717-725.
53. Mantovani A. Cancer: inflaming metastasis. Nature 2009, 457:36-37.
54. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
55. Matthews C., Gorenne I., Scott S., Figg N., Kirkpatrick P., Ritchie A., Goddard M., Bennett M. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ. Res. 2006, 99:156-164.
56. Michaloglou C., Vredeveld L.C., Mooi W.J., Peeper D.S. BRAF(E600) in benign and malignant human tumours. Oncogene 2008, 27:877-895.
57. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005, 436:720-724.
58. Minamino T., Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 2007, 100:15-26.
59. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 2009, 15:1082-1087.
60. Mosieniak G., Sikora E. Polyploidy: the link between senescence and cancer. Curr. Pharm. Des. 2010, 16:734-740.
61. Nakamura A.J., Chiang Y.J., Hathcock K.S., Horikawa I., Sedelnikova O.A., Hodes R.J., Bonner W.M. Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence. Epigenet. Chromatin 2008, 1:6.
62. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003, 113(6):703-716.
63. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973, 41:181-190.
64. Parrinello S., Samper E., Krtolica A., Goldstein J., Melov S., Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell. Biol. 2003, 5:741-747.
65. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., Higashimoto Y., Appella E., Minucci S., Pandolfi P.P., Pelicci P.G. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000, 406:207-210.
66. Prieur A., Peeper D.S. Cellular senescence in vivo: a barrier to tumorigenesis. Curr. Opin. Cell Biol. 2008, 20:150-155.
67. Ressler S., Bartkova J., Niederegger H., Bartek J., Scharffetter-Kochanek K., Jansen-Durr P., Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006, 5:379-389.
68. Rodier F., Coppe J.P., Patil C.K., Hoeijmakers W.A., Munoz D.P., Raza S.R., Freund A., Campeau E., Davalos A.R., Campisi J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 2009, 11:973-979.
69. Romanov S.R., Kozakiewicz B.K., Holst C.R., Stampfer M.R., Haupt L.M., Tlsty T.D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001, 409:633-637.
70. Rubin H. Cell aging in vivo and in vitro. Mech. Ageing Dev. 1997, 98:1-35.
71. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
72. Sansoni P., Vescovini R., Fagnoni F., Biasini C., Zanni F., Zanlari L., Telera A., Lucchini G., Passeri G., Monti D., Franceschi C., Passeri M. The immune system in extreme longevity. Exp. Gerontol. 2008, 43:61-65.
73. Sedelnikova O.A., Horikawa I., Zimonjic D.B., Popescu N.C., Bonner W.M., Barrett J.C. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 2004, 6:168-170.
74. Serrano M., Blasco M.A. Putting the stress on senescence. Curr. Opin. Cell Biol. 2001, 13:748-753.
75. Serrano M., Lin A.W., McCurrach M.E., Beach D., Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
76. Severino J., Allen R.G., Balin S., Balin A., Cristofalo V.J. Is beta-galactosidase staining a marker of senescence in vitro and in vivo?. Exp. Cell Res. 2000, 257:162-171.
77. Shay J.W., Roninson I.B. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004, 23:2919-2933.
78. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
79. Shibata K.R., Aoyama T., Shima Y., Fukiage K., Otsuka S., Furu M., Kohno Y., Ito K., Fujibayashi S., Neo M., Nakayama T., Nakamura T., Toguchida J. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 2007, 25:2371-2382.
80. Sliwinska M.A., Mosieniak G., Wolanin K., Babik A., Piwocka K., Magalska A., Szczepanowska J., Fronk J., Sikora E. Induction of senescence with doxorubicin leads to increased genomic instability of HCT116 cells. Mech. Ageing Dev. 2009, 130:24-32.
81. Sordet O., Redon C.E., Guirouilh-Barbat J., Smith S., Solier S., Douarre C., Conti C., Nakamura A.J., Das B.B., Nicolas E., Kohn K.W., Bonner W.M., Pommier Y. Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks. EMBO Rep. 2009, 10:887-893.
82. Stein G.H., Drullinger L.F., Robetorye R.S., Pereira-Smith O.M., Smith J.R. Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:11012-11016.
83. Takubo K., Aida J., Izumiyama-Shimomura N., Ishikawa N., Sawabe M., Kurabayashi R., Shiraishi H., Arai T., Nakamura K.-N. Changes of telomere length with aging. Geriatr. Gerontol. Int. 2010, 10:S197-S206.
84. Tchkonia T., Morbeck D.E., Von Zglinicki T., Van Deursen J., Lustgarten J., Scrable H., Khosla S., Jensen M.D., Kirkland J.L. Fat tissue, aging, and cellular senescence. Aging Cell 2010, 9:667-684.
85. Toussaint O., Medrano E.E., von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 2000, 35:927-945.
86. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128:83-91.
87. Vasto S., Candore G., Duro G., Lio D., Grimaldi M.P., Caruso C. Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics 2007, 8:1735-1745.
88. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., Harley C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 1993, 52:661-667.
89. Vijg J., Campisi J. Puzzles, promises and a cure for ageing. Nature 2008, 454(7208):1065-1071.
90. von Zglinicki T, Petrie J., Kirkwood T.B. Telomere-driven replicative senescence is a stress response. Nat. Biotechnol. 2003, 21:229-230.
91. Wagner M., Hampel B., Bernhard D., Hala M., Zwerschke W., Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp. Gerontol. 2001, 36(8):1327-1347.
92. Walen K.H. Human diploid fibroblast cells in senescence; cycling through polyploidy to mitotic cells. In Vitro Cell Dev. Biol. Anim. 2006, 42:216-224.
93. Wang C., Jurk D., Maddick M., Nelson G., Martin-Ruiz C., von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009, 8(3):311-323.
94. Wojda A., Zietkiewicz E., Mossakowska M., Pawlowski W., Skrzypczak K., Witt M. Correlation between the level of cytogenetic aberrations in cultured human lymphocytes and the age and gender of donors. J. Gerontol. A: Biol. Sci. Med. Sci. 2006, 61:763-772.
95. Yang D., McCrann D.J., Nguyen H., St Hilaire C., DePinho R.A., Jones M.R., Ravid K. Increased polyploidy in aortic vascular smooth muscle cells during aging is marked by cellular senescence. Aging Cell 2007, 6:257-260.
96. Yang D.G., Liu L., Zheng X.Y. Cyclin-dependent kinase inhibitor p16(INK4a) and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Res. Rev. 2008, 7:137-146.
97. Ye X., Zerlanko B., Zhang R., Somaiah N., Lipinski M., Salomoni P., Adams P.D. Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol. Cell Biol. 2007, 27:2452-2465.
98. Young A.R., Narita M. Connecting autophagy to senescence in pathophysiology. Curr. Opin. Cell Biol. 2010, 22:234-240.
99. Zhang P., Dilley C., Mattson M.P. DNA damage responses in neural cells: focus on the telomere. Neuroscience 2007, 145:1439-1448.